radioprotection


Also found in: Dictionary, Medical.
Related to radioprotection: Radiation protection
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to radioprotection

protection against harmful effects of radiation

Related Words

References in periodicals archive ?
As the principal mechanism of the radiation damage is the production of free radicals and the scavenging of these free radicals by conjugation Phase II enzymes results in radioprotection.
A comparative study of radioprotection by Ocimum flavonoids and synthetic aminothiol protectors in the mouse.
Many forms of Ocimum sanctum and Ocimum basilicum (holly basil) such as the ethanolic extract, flavonoids, seed oil, phenolic compounds, root extract, leaf extract, aqueous extract, fixed oil, fresh leaf paste and leaves in the diet, have been studied and have shown promising results for bone marrow radioprotection (Ganasoundri et al.
The increase in research and development expense for the nine month period was due mainly to the growth in the Company's laboratory operations, as well as preclinical and clinical activities and personnel associated with advancing the Company's radioprotection drug candidate, NEUMUNE(TM), through development.
Key words: Triphala, radiation, mice, survival, acute toxicity, radioprotection, Terminalia chebula Retz.
Key words: Radioprotection, Hippophae rhamnoides, lethal irradiation, herbal radioprotector, antioxidant
The increase in research and development expense was due mainly to the growth in the Company's laboratory operations, as well as preclinical and clinical activities and personnel associated with advancing the Company's radioprotection drug candidate, NEUMUNE(TM), through development.
The increase in research and development expenses in the first quarter of 2005 was due mainly to the growth in the Company's laboratory operations, preclinical activities and personnel associated with advancing the Company's radioprotection drug development candidate, NEUMUNE(TM).
The increase in research and development expense was due mainly to the growth in the Company's laboratory operations, preclinical activities and personnel, ongoing testing of the Company's radioprotection drug development candidate, NEUMUNE(TM), as well as its investment in Congressional Pharmaceutical Corporation (CPC), which was expensed as in-process R&D in the first quarter of 2004.
The increase in research and development expense in the first quarter of 2004 was due mainly to the growth in the Company's laboratory operations, preclinical activities and personnel, ongoing testing of the Company's radioprotection drug development candidate, NEUMUNE(TM), as well as its investment in Congressional Pharmaceutical Corporation (CPC), which was expensed as in-process R&D.
Contract notice: Follow-up of studies and work of the market current strong, weak currents, instrumentation of radioprotection.
The decrease in research and development that was seen through the first three quarters of 2003 relative to 2002 was partially offset by an increase in research and development expense in the fourth quarter of 2003, primarily as a result of more extensive testing of the Company's radioprotection drug development candidate, NEUMUNE (HE2100).
Additional services: intervention of a Technician qualified in Radioprotection.
The Company expects to apply for approval of HE2100 for radioprotection in 2004.